Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haijun Tian

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 8, 2023
Secreted phosphoprotein 24 kD (Spp24) inhibits the growth of human osteosarcoma through the BMP-2/Smad signaling pathwayHongfang Chen, Chenshuang Li, Tangjun Zhou, et al.
Spine|April 11, 2014
Effect of cervical kyphotic deformity type on the motion characteristics and dynamic spinal cord compressionMonchai Ruangchainikom, Michael D Daubs, Akinobu Suzuki, et al.
Cellular Signalling|May 17, 2025
Regulation of diabetic disc degeneration: The role of AGEAT/miR-204-5p/Mapk4 axis in nucleus pulposus cells' mitochondrial function and apoptosisZhiguang Zhang, Ouqiang Wu, Jiahao Ying, et al.
The Spine Journal : Official Journal of the North American Spine Society|December 3, 2014
Comparison of a novel oxysterol molecule and rhBMP2 fusion rates in a rabbit posterolateral lumbar spine modelTrevor P Scott, Kevin H Phan, Haijun Tian, et al.
Biochemical and Biophysical Research Communications|September 4, 2015
Secreted phosphoprotein 24 kD (Spp24) inhibits growth of human pancreatic cancer cells caused by BMP-2Chen-Shuang Li, Haijun Tian, Min Zou, et al.
Clinical Pharmacology and Therapeutics|March 13, 2025
Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical PerspectiveJie Chen, Lei Nie, Shiowjen Lee, et al.
Clinical Pharmacology and Therapeutics|February 14, 2025
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical PerspectiveJie Chen, Susan Gruber, Hana Lee, et al.
European Journal of Dermatology : EJD|January 31, 2019
The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study)Jean-Philippe Lacour, Abdallah Khemis, Françoise Giordano-Labadie, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 10, 2019
Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathwayHaijun Tian, Tangjun Zhou, Hongfang Chen, et al.
Stem Cell Research & Therapy|May 1, 2025
Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanismsYuxin Jin, Ouqiang Wu, Zhihua Chen, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 8, 2023
Secreted phosphoprotein 24 kD (Spp24) inhibits the growth of human osteosarcoma through the BMP-2/Smad signaling pathwayHongfang Chen, Chenshuang Li, Tangjun Zhou, et al.
Spine|April 11, 2014
Effect of cervical kyphotic deformity type on the motion characteristics and dynamic spinal cord compressionMonchai Ruangchainikom, Michael D Daubs, Akinobu Suzuki, et al.
Cellular Signalling|May 17, 2025
Regulation of diabetic disc degeneration: The role of AGEAT/miR-204-5p/Mapk4 axis in nucleus pulposus cells' mitochondrial function and apoptosisZhiguang Zhang, Ouqiang Wu, Jiahao Ying, et al.
The Spine Journal : Official Journal of the North American Spine Society|December 3, 2014
Comparison of a novel oxysterol molecule and rhBMP2 fusion rates in a rabbit posterolateral lumbar spine modelTrevor P Scott, Kevin H Phan, Haijun Tian, et al.
Biochemical and Biophysical Research Communications|September 4, 2015
Secreted phosphoprotein 24 kD (Spp24) inhibits growth of human pancreatic cancer cells caused by BMP-2Chen-Shuang Li, Haijun Tian, Min Zou, et al.
Clinical Pharmacology and Therapeutics|March 13, 2025
Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical PerspectiveJie Chen, Lei Nie, Shiowjen Lee, et al.
Clinical Pharmacology and Therapeutics|February 14, 2025
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical PerspectiveJie Chen, Susan Gruber, Hana Lee, et al.
European Journal of Dermatology : EJD|January 31, 2019
The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study)Jean-Philippe Lacour, Abdallah Khemis, Françoise Giordano-Labadie, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 10, 2019
Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathwayHaijun Tian, Tangjun Zhou, Hongfang Chen, et al.
Stem Cell Research & Therapy|May 1, 2025
Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanismsYuxin Jin, Ouqiang Wu, Zhihua Chen, et al.
Pageof 12